CID is dedicated to contributing to human welfare by improving the quality of patient care and after-care through the development of innovative, minimally invasive implantable devices, procedures and therapies. Inherent bioengineering technologies allow CID to advance in the areas of its expertise to offer the company's investors a fair return and its customers the necessary tools to meet new challenges.